z-logo
open-access-imgOpen Access
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
Author(s) -
Katie Ewer,
Tommy Rampling,
Navin Venkatraman,
Georgina Bowyer,
Daniel Wright,
Teresa Lambe,
Egeruan B. Imoukhuede,
Ruth Payne,
Sarah Katharina Fehling,
Thomas Strecker,
Nadine Biedenkopf,
Verena Krähling,
Claire Maria Tully,
Nick J. Edwards,
Emma M. Bentley,
Dhanraj Samuel,
Geneviève M. Labbé,
Jing Jin,
Malick M. Gibani,
Alice Minhinnick,
Morven Wilkie,
Ian Poulton,
Natalie Lella,
Rachel Roberts,
Felicity Hartnell,
Carly M. Bliss,
Kailan Sierra-Davidson,
Jonathan Powlson,
Eleanor Berrie,
Richard S. Tedder,
François Roman,
Iris De Ryck,
Alfredo Nicosia,
Nancy J. Sullivan,
Daphne A. Stanley,
Olivier Tshiani Mbaya,
Julie E. Ledgerwood,
Richard Schwartz,
Loredana Siani,
Stefano Colloca,
Antonella Folgori,
Stefania Di Marco,
Riccardo Cortese,
Edward Wright,
Stephan Becker,
Barney S. Graham,
Richard A. Koup,
Myron M. Levine,
Ariane Volkmann,
Paul Chaplin,
Andrew J. Pollard,
Simon J. Draper,
W. Ripley Ballou,
Alison M. Lawrie,
Sarah C. Gilbert,
Adrian V. S. Hill
Publication year - 2015
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1411627
Subject(s) - virology , ebola vaccine , ebola virus , neutralizing antibody , vaccination , ebolavirus , medicine , titer , antibody , vaccinia , vesicular stomatitis virus , virus , neutralization , biology , immunology , recombinant dna , biochemistry , gene
The West African outbreak of Ebola virus disease that peaked in 2014 has caused more than 11,000 deaths. The development of an effective Ebola vaccine is a priority for control of a future outbreak.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom